Send to

Choose Destination
Biken J. 1984 Sep;27(2-3):39-42.

Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.


Clinical and serological follow-up studies were made on 257 healthy children who had received live varicella vaccine (strain Oka) in Showa Hospital. Good antibody responses were shown with a seroconversion rate of 98.4% (253/257) by the immune adherence hemagglutination test. Mild adverse reactions were observed in 11 of the vaccinated children. During observation periods of 6 months to 4 years, 6 of the 253 children who were successfully vaccinated contracted mild varicella, while all 4 vaccinees who showed no primary immune response contracted mild to moderate clinical varicella. It is concluded that this vaccine is highly immunogenic and causes few clinical reactions in normal children.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center